Back
BioXcel Therapeutics Vs. Cytokinetics Industry Stock Comparison
Sell
36
BTAI
BioXcel Therapeutics
Last Price:
2.97
Seasonality Move:
13.65%
Sell
39
CYTK
Cytokinetics
Last Price:
65.57
Seasonality Move:
9.34%
Sell
36
BioXcel Therapeutics (BTAI)
is a Sell
Is BioXcel Therapeutics a Buy, Sell or Hold?
- The current BioXcel Therapeutics [BTAI] share price is $2.97. The Score for BTAI is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
- BTAI is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
39
Cytokinetics (CYTK)
is a Sell
Is Cytokinetics a Buy, Sell or Hold?
- The current Cytokinetics [CYTK] share price is $65.57. The Score for CYTK is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
- CYTK is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
BTAI Stock Price Chart
What is BioXcel Therapeutics's stock price today?
-
The BioXcel Therapeutics share price today is $2.97
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BTAI is experiencing slight buying pressure.
CYTK Stock Price Chart
What is Cytokinetics's stock price today?
-
The Cytokinetics share price today is $65.57
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CYTK is experiencing selling pressure, which indicates risk of future bearish movement.
BTAI Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.02 | Sell |
| Relative Strength Index (14 RSI): | 57.56 | Buy |
| Chaikin Money Flow: | 163777 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.64 - 2.86) | Buy |
| Bollinger Bands (100): | (2.62 - 3.4) | Sell |
CYTK Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.99 | Sell |
| Relative Strength Index (14 RSI): | 39 | Sell |
| Chaikin Money Flow: | -1251323 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (67.09 - 72.63) | Sell |
| Bollinger Bands (100): | (50.98 - 86.16) | Sell |
BTAI Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.76 | Buy |
| 20-day SMA: | 2.73 | Buy |
| 50-day SMA: | 2.89 | Buy |
| 200-day SMA: | 4.02 | Sell |
| 8-day EMA: | 2.78 | Buy |
| 20-day EMA: | 2.76 | Buy |
| 50-day EMA: | 2.87 | Buy |
| 200-day EMA: | 5.68 | Sell |
CYTK Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 67.87 | Sell |
| 20-day SMA: | 70.47 | Sell |
| 50-day SMA: | 70.8 | Sell |
| 200-day SMA: | 50.8 | Buy |
| 8-day EMA: | 67.85 | Sell |
| 20-day EMA: | 69.24 | Sell |
| 50-day EMA: | 69.78 | Sell |
| 200-day EMA: | 57.15 | Buy |
BioXcel Therapeutics Earnings Growth & BTAI Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.63 per share, a decrease next quarter of $0.00 per share, an increase this year of $3.34 per share, and an increase next year of $1.29 per share.
Cytokinetics Earnings Growth & CYTK Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.38 per share, a decrease next quarter of $0.06 per share, an increase this year of $0.31 per share, and an increase next year of $1.28 per share.
BioXcel Therapeutics Technical Analysis
| Apr 10 | Apr 11 | Apr 12 | Apr 15 | Apr 16 | Apr 17 | Apr 18 | Apr 19 | Apr 22 | Apr 23 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Cytokinetics Technical Analysis
| Apr 10 | Apr 11 | Apr 12 | Apr 15 | Apr 16 | Apr 17 | Apr 18 | Apr 19 | Apr 22 | Apr 23 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||